Life SciencesGeneticsMolecular GeneticsCarcinogenesisCytogeneticsDna RepairChromosomal AbnormalitiesChromosomal DisordersChromosomal InstabilityDna Repair DefectsStructural Chromosome AbnormalitiesX-chromosome InactivationFragile SitesThymidine Nucleotide MetabolismX-chromosome Inactivation In CancerX-chromosome Reactivation
Experiments designed to illuminate the mechanism by which folic acid and thymidine inhibit expression of the Xq28 fragile site in human lymphocytes are described. The fragile site is induced by 5-fluorodeoxyuridine (FUdR), a potent inhibitor of thymidylate synthetase, in the presence of otherwise inhibiting concentrations of folic acid but not in the presence of thymidine. These results indicate that the fragile site is expressed because of depletion of deoxythymidine monophosphate (dTMP) available for DNA synthesis.
10